|[March 20, 2013]
Research and Markets: Healthcare, Regulatory and Reimbursement Landscape - Egypt
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/hc7bsf/healthcare)
has announced the addition of the "Healthcare,
Regulatory and Reimbursement Landscape - Egypt" report to their
Egypt's Healthcare Expansion to Continue despite Deep Civil Unrest
Despite a number of major socio-political issues, including widespread
public discontent and political instability, Egypt's healthcare sector
will demonstrate relatively impressive growth in the future, predicts
research and consulting firm The authors.
The company's new report forecasts Egypt's pharmaceutical market to
climb from a value of US$3 billion in 2012 to US$5.3 billion in 2020,
while the county's medical devices market is expeted to grow from
US$789m to US$1.1 billion during the same period.
Pricing policies introduced in May 2011, which linked the price of
pharmaceuticals with international prices, are expected to act as a key
growth driver for Egypt's healthcare sector in the coming years.
Additionally, last October's proposal of a new universal healthcare law
that will provide health insurance coverage to the entire Egyptian
population should prove a significant boost to healthcare revenue once
introduced across the country.
However, the social turmoil currently permeating Egypt has given rise to
a number of significant obstacles to growth. The North African nation
has a population of approximately 80 million, the majority of whom are
of working-age, but unemployment levels have crept up in recent years
and stood at 12.5% by the end of 2012.
Political instability has also been a major problem since the revolution
in January 2011. Egypt's economy is currently facing high inflation, a
weakening of Foreign Direct Investment (FDI) and last year the country's
fiscal deficit increased to 10% - a factor that may substantially affect
how much the Egyptian government allocates to healthcare spending in the
This report provides an overview of the pharmaceutical and medical
devices markets, comprising size, segmentation and key drivers and
This report was built using data and information sourced from
proprietary databases, primary and secondary research, and in-house
analysis conducted by The authors's team of industry experts.
For more information visit http://www.researchandmarkets.com/research/hc7bsf/healthcare
[ Back To Insurance Technology's Homepage ]